Dr. med. Dirk Manski



 You are here: Urology Textbook > Prostate > BPH > Treatment algorithm


Treatment Algorithm for Benign Prostatic Hyperplasia (BPH)


Review literature: (Burnett und Wein, 2006) (DGU-Guideline: diagnostic work-up, 2009) (DGU-Guideline: treatment, 2009) (EAU-Guideline: Oelke et al, 2010)

Absolute Indications for Surgical Treatment of BPH


Surgical Treatment Options:

Medical Treatment for BPH:

BPH medication is indicated for significant and disturbing symptoms and if there are not absolute indications for surgical therapy present (see above). The following drug classes for the treatment of BPH are available, some drugs may be combined:

Watchful waiting in BPH

Watchful waiting in BPH is possible, if there is no need for surgery and the patient accepts his (moderate) symptoms. 40% of the patients initially assigned to watchful waiting experience improvement of symptoms. 10–27% of the patients are going to have surgery for disease progression, risk factors are prostate volume (>40 ml), PSA concentration (>3.2 mg/ml), and a high IPSS.

Algorithm for Initial Diagnosis and Treatment of Men with LUTS due to BPH


Fig. diagnostic work-up of LUTS: algorithm for diagnosis and treatment of BPH at initial presentation, in accordance to the guidelines of the AUA 2003 [Kaplan, 2004a], DGU 2009 (DGU Guideline: diagnostic work-up, 2009) (DGU-guideline: treatment, 2009) and EAU 2010 (Oelke et al, 2010):
(*) Despite adequate medical therapy.
(**) Urodynamics should be considered in men under 50 years, in patients over 80 years, more than 300 ml residual urine, maximum urinary flow >15 ml/s, suspected neurogenic bladder dysfunction, after radical pelvic surgery, after unsuccessful non-invasive therapy.
(***) Not an option after urinary retention or hematuria.
Fig. diagnostic work-up of LUTS: algorithm for diagnosis and treatment of BPH at initial presentation, in accordance to the guidelines of AUA, DGU and EAU







Index: 1–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



References



Burnett und Wein 2006 BURNETT, A. L. ; WEIN, A. J.:
Benign prostatic hyperplasia in primary care: what you need to know.
In: J Urol
175 (2006), Nr. 3 Pt 2, S. S19–24

Chapple 2004 CHAPPLE, C. R.:
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.
In: BJU Int
94 (2004), Nr. 5, S. 738–44

DGU-Guidelines: diagnostic work-up
Leitlinien der Deutschen Urologen zur Diagnostik des benignen Prostatasyndroms (BPS).
In: Urologe A
48 (2009), S. 1356–60, 1362–4


DGU-Guidelines: treatment
Leitlinien der Deutschen Urologen zur Therapie des benignen Prostatasyndroms (BPS).
In: Urologe A
48 (2009), S. 1503–1516




Oelke, M.; Bachmann, A.; Descazeaud, A. & Emberton, M.
Guidelines on conservative treatment of non-neurogenic male LUTS
www.uroweb.org, 2010.


Reich u.a. 2006 REICH, O. ; GRATZKE, C. ; STIEF, C. G.:
Techniques and long-term results of surgical procedures for BPH.
In: Eur Urol
49 (2006), Nr. 6, S. 970–8; discussion 978


  Deutsche Version: Therapie der benignen Prostatahyperplasie